I agree, $/oz too low at the moment, as soon as drill results come in there is likely to be a rise to cause AZX to match peers.DYOR, My opinion only
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%